TCT-107 Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Complete 1-Year Outcomes from the SURTAVI Trial

Abstract

The SURTAVI trial compared clinical outcomes in patients with severe, symptomatic aortic stenosis at intermediate surgical risk. Using a novel Bayesian statistical method, transcatheter aortic valve replacement (TAVR) with a self-expanding bioprosthesis was shown to be noninferior to surgical aortic